Company Overview of KAI Pharmaceuticals, Inc.
Key Executives for KAI Pharmaceuticals, Inc.
|Gregory M. Bell M.D.||9 Relationships||Chief Medical Officer and Senior Vice President of Development||--|
KAI Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Richard D. DiMarchi Ph.D.||29 Relationships||Twilight Venture Partners, LLC||64|
|Steven F. Dowdy Ph.D.||8 Relationships||Deep Genomics Inc.||--|
|Susan Serota Taylor Ph.D.||16 Relationships||J. Craig Venter Institute, Inc.||--|
|Robert Tjian Ph.D.||11 Relationships||Howard Hughes Medical Institute||68|
KAI Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|There is no committee data available.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.